http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114724700-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f10c42037f0c11736eb81a6a6076f7 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-214 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06Q10-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q10-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 |
filingDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_807c5ad218a583bae1a94d71c2f9a4c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae60560db59d5f91c990d377735cdd95 |
publicationDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-114724700-A |
titleOfInvention | Method, device and electronic device for constructing a prediction model for lymphocyte count recovery |
abstract | The invention provides a method, device and electronic equipment for constructing a lymphocyte count recovery prediction model, and relates to the technical field of cancer risk assessment, including acquiring pre-radiotherapy clinical feature information and post-radiotherapy medical examination information of training set objects; The clinical feature information is used to classify the training set objects, and the classification results of the training set objects are obtained; the progression-free survival period value of the training set objects is determined based on the clinical feature information of the training set objects; based on the classification results of the training set objects, the progression-free survival period value A survival curve was drawn; a lymphocyte count recovery prediction model was constructed based on the associated values of the predictors. This application can comprehensively utilize the complementary effect of each independent factor of patients, quantitatively and accurately evaluate the recovery probability of early-stage NSCLC patients after receiving SBRT, improve the prediction effect on the survival of NSCLC patients after receiving SBRT, and provide close monitoring and monitoring of high-risk patients in a timely manner. Additional therapeutic interventions. |
priorityDate | 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450503 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578282 |
Total number of triples: 21.